MUTATION -198 (T->C) Agamma; the British nd-HPFH
 
IDENTIFICATION Cloning and DNA sequencing; restriction enzyme analysis
HEMATOLOGY IN HETEROZYGOTE(S)
Normal (Ref. 1)Normal (Ref. 4)
Hb F  8.5 (3.9-13.0)% (n=10)Hb F  3.8 (1.8-5.8)% (n=12)
Ggamma  8.0%; Agamma  92.0% (gammaCB-3)nearly 100% Agamma (rp-HPLC)
Hb A2  2.35 (2.0-2.7)% (n=10)Hb A2  2.4 (1.9-2.7)% (n=5)

HEMATOLOGY IN HOMOZYGOTE(S) Three adults:  
Hb F  19.4; 19.6; 20.4%;
Ggamma  8.0%;
Agamma  92.0% (gammaCB-3);
Hb A2  1.7; 1.6; 1.6%
OCCURRENCE In a British family and an Australian family
HAPLOTYPE Haplotype I [+ - - - - + + +]
FOUND IN COMBINATION WITH ABNORMAL HB(S) Not reported
FOUND IN COMBINATION WITH BETA-THAL ALLELE(S) With beta-thal (Hb A2 5.2%; Hb F 7.9%; nearly 100% Agamma by rp-HPLC)
MECHANISM The mutation alters the affinity of a transacting factor [see also -202 (C->G) Ggamma]
       
REFERENCES
1. Weatherall, D.J., Cartner, R., Clegg, J.B., Macrae, I.A., and Mackenzie, A.: Br. J. Haematol., 29:205, 1975.
2. Tate, V.E., Wood, W.G., and Weatherall, D.J.: Blood, 68:1389, 1986.
3. Donald, J.A., Lammi, A., and Trent, R.J.: Hum. Genet., 80:69, 1988.
4. Harvey, M.P., Motum, P., Lindeman, R., and Trent, R.J.: Exp. Hematol., 20:320, 1992.


This material is from the book A Syllabus of Thalassemia Mutations (1997) by Titus H.J. Huisman, Marianne F.H. Carver, and Erol Baysal, published by The Sickle Cell Anemia Foundation in Augusta, GA, USA. Copyright © 1997 by Titus H.J. Huisman. All rights reserved. Neither this work nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, microfilming and recording, or by any information storage and retrieval systems, without permission in writing from the Author.